Product NDC: | 62646-798 |
Proprietary Name: | Anticoagulant Sodium Citrate |
Non Proprietary Name: | Sodium Citrate |
Active Ingredient(s): | 10 g/250mL & nbsp; Sodium Citrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62646-798 |
Labeler Name: | Medsep Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA760305 |
Marketing Category: | NDA |
Start Marketing Date: | 20110415 |
Package NDC: | 62646-798-60 |
Package Description: | 250 mL in 1 BAG (62646-798-60) |
NDC Code | 62646-798-60 |
Proprietary Name | Anticoagulant Sodium Citrate |
Package Description | 250 mL in 1 BAG (62646-798-60) |
Product NDC | 62646-798 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sodium Citrate |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110415 |
Marketing Category Name | NDA |
Labeler Name | Medsep Corporation |
Substance Name | SODIUM CITRATE |
Strength Number | 10 |
Strength Unit | g/250mL |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |